Scaling cell therapy supply chains during a pandemic
Achieving donor pool sustainability and cell therapy supply chain success
Subscribe
Get updates from the Cell Lines Blog delivered to your inbox.
Being an NMDP/Be The Match courier during COVID-19
Making essential treatments possible in the midst of a pandemic
How CAR-T reimbursement discussions help advance the field
Proposed IPPS rule an encouraging step towards a clearer payment process
Be The Match BioTherapies CEO’s path to biotech
How a personal experience led her on a mission to save lives through cellular therapy
5 Qualities to Seek in Your Cell Therapy Supply Chain Vendor
Considerations to help lower your cell or gene therapy logistics risk
Overcoming autologous cell therapy logistics challenges in the age of COVID-19
Experienced team for managed logistics is key
Can cell therapies unlock the COVID-19 mystery?
The promise of MSC therapies to treat deadly manifestations of cytokine storms
How COVID-19 is changing the production of cell therapies
Implementation of contingency plans allows for continued progress in therapy development
Managing donor collections during the COVID-19 pandemic
Why a diverse apheresis center network is critical to business continuity